Market Overview The global antifibrinolytic drugs market reached a size of USD 17.6 Billion in 2024. It is projected to grow to USD 25.0 Billion by 2033, with a compound annual growth rate (CAGR) of 3.77% during the forecast period from 2025 to 2033. These drugs are primarily used to promote blood clot formation by inhibiting plasminogen activation, preventing fibrinolysis, and controlling...